Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment
This study has been terminated.
( Protocol objective could not be met. A new study with amended eligibility criteria will be developed. )
Study NCT00800150
Information provided by City of Hope Medical Center
First Received on November 27, 2008.
Last Updated on July 28, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
